recurrent Gliosarcoma
Showing 1 - 25 of 7,855
Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Houston (other, biological, procedure)
Active, not recruiting
- Recurrent Glioblastoma
- Recurrent Gliosarcoma
- Laboratory Biomarker Analysis
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Dec 19, 2022
Giant Cell Glioblastoma, Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Rochester (Laboratory Biomarker Analysis,
Active, not recruiting
- Giant Cell Glioblastoma
- +2 more
- Laboratory Biomarker Analysis
- Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine
-
Rochester, MinnesotaMayo Clinic
Jan 4, 2023
Recurrent Glioblastoma, Recurrent Gliosarcoma, Recurrent Astrocytoma, Grade IV Trial in Ann Arbor (drug, radiation, procedure)
Recruiting
- Recurrent Glioblastoma
- +5 more
- Mycophenolate Mofetil
- +3 more
-
Ann Arbor, MichiganUniversity of Michigan Rogel Cancer Center
Jul 7, 2022
Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte
Withdrawn
- Recurrent Anaplastic Astrocytoma
- +7 more
- Neural Stem Cells-expressing CRAd-S-pk7
- Resection
- (no location specified)
Nov 22, 2022
Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Atlanta (Liothyronine, Lomustine, Methimazole)
Recruiting
- Recurrent Glioblastoma
- Recurrent Gliosarcoma
- Liothyronine
- +2 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Feb 23, 2022
High Grade Astrocytic Tumor, Recurrent Glioblastoma, IDH-Wildtype, Recurrent Gliosarcoma Trial in Rochester (Biospecimen
Not yet recruiting
- High Grade Astrocytic Tumor
- +2 more
- Biospecimen Collection
- +2 more
-
Rochester, MinnesotaMayo Clinic
Jul 18, 2022
Recurrent Gliosarcoma, Recurrent Supratentorial Glioblastoma, Supratentorial Gliosarcoma Trial in Houston (Cord Blood-derived
Not yet recruiting
- Recurrent Gliosarcoma
- +2 more
- Cord Blood-derived Expanded Allogeneic Natural Killer Cells
- Resection
-
Houston, TexasM D Anderson Cancer Center
May 24, 2022
Gliosarcoma, Recurrent Glioblastoma Trial in Chicago (Laboratory Biomarker Analysis, Pharmacological Study, Targeted Molecular
Completed
- Gliosarcoma
- Recurrent Glioblastoma
- Laboratory Biomarker Analysis
- +2 more
-
Chicago, IllinoisNorthwestern University
Aug 5, 2022
Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte
Active, not recruiting
- Recurrent Anaplastic Astrocytoma
- +6 more
- Carboxylesterase-expressing Allogeneic Neural Stem Cells
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jun 7, 2022
Recurrent High Grade Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial (PCI 24781, Temozolomide)
Not yet recruiting
- Recurrent High Grade Glioma
- +4 more
- PCI 24781
- Temozolomide
- (no location specified)
Jan 24, 2023
Astrocytoma, Grade IV, Giant Cell Glioblastoma, Glioblastoma Multiforme Trial run by the NCI (Radiation)
Active, not recruiting
- Astrocytoma, Grade IV
- +3 more
- Radiation
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Glioblastoma Multiforme, Anaplastic Astrocytoma, Gliosarcoma Trial in Birmingham (M032, Pembrolizumab)
Recruiting
- Glioblastoma Multiforme
- +2 more
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Jan 30, 2023
Glioblastoma Multiforme of Brain, Anaplastic Astrocytoma of Brain, Gliosarcoma of Brain Trial in Birmingham (C134)
Active, not recruiting
- Glioblastoma Multiforme of Brain
- +2 more
- C134
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Sep 19, 2022
Glioblastoma Multiforme of Brain, Glioma, Sarcomatous Trial in Buffalo (photochemo using
Not yet recruiting
- Glioblastoma Multiforme of Brain
- Glioma, Sarcomatous
- photochemotherapy using 3-(1-Butyloxy)ethyl-3-deacetyl-bacteriopurpurin-18-n-butylimide methyl ester(Photobac®)
-
Buffalo, New YorkRoswell Park Cancer
Sep 26, 2022
Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling
Recruiting
- Recurrent Childhood Acute Myeloid Leukemia
- +17 more
-
Miami, FloridaNicklaus Children's Hospital
May 13, 2023
Ex Vivo Drug Sensitivity Testing and Mutation Profiling
Completed
- Recurrent Childhood Acute Myeloid Leukemia
- +13 more
-
Miami, FloridaNicklaus Children's Hospital
Jan 18, 2023
Malignant Supratentorial Tumor, Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Houston (Lonafarnib, Temozolomide)
Active, not recruiting
- Malignant Supratentorial Neoplasm
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Dec 13, 2021
Recurrent Glioblastoma Multiforme, Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma or Gliosarcoma Trial in
Active, not recruiting
- Recurrent Glioblastoma Multiforme
- +2 more
- M032 (NSC 733972)
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Jan 26, 2022
Recurrent Glioblastoma, Recurrent Gliosarcoma, Recurrent Supratentorial Glioblastoma Trial in Los Angeles (drug, radiation,
Withdrawn
- Recurrent Glioblastoma
- +3 more
- Akt/ERK Inhibitor ONC201
- +2 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
May 10, 2021
Glioblastoma, Adult Gliosarcoma, Tumors, Brain Trial in Seongnam (MSC11FCD)
Enrolling by invitation
- Glioblastoma
- +4 more
-
Seongnam, Kyunggido, Korea, Republic ofBundang CHA Medical Center
Jan 6, 2022
Anaplastic Astrocytoma, Anaplastic Ependymoma, Anaplastic Oligodendroglioma Trial in United States (other, drug, procedure)
Active, not recruiting
- Anaplastic Astrocytoma
- +6 more
- Laboratory Biomarker Analysis
- +4 more
-
Los Angeles, California
- +11 more
Jul 1, 2022
Diffuse Intrinsic Pontine Glioma, Pediatric Brainstem Glioma, Pediatric Brainstem Gliosarcoma, Recurrent Trial in Boston
Active, not recruiting
- Diffuse Intrinsic Pontine Glioma
- +5 more
-
Boston, Massachusetts
- +1 more
May 3, 2022
CNS Tumors, Glioblastoma, Gliosarcoma, Adult Trial run by the (ONC206)
Recruiting
- Central Nervous System Neoplasms
- +22 more
-
Bethesda, MarylandNational Institutes of Health
Mar 1, 2022
Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma Trial in Duarte (biological,
Completed
- Adult Anaplastic Astrocytoma
- +6 more
- E. coli CD-expressing genetically modified neural stem cells
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Sep 28, 2021